Erratum

In the article by Akizawa et al. entitled “Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies” [Am J Nephrol. 2019;49:271–80, DOI: 10.1159/000499111], in Table 1, the mean CRP (SD) values for DIALOGUE 5 currently read 0.7 (1.2), 0.6 (0.8), and 0.7 (1.1) for molidustat, epoetin, and total, respectively. These values should be 7.5 (12.3), 5.8 (7.7), and 6.9 (10.9), respectively.